AnalystsSteve SeedhouseSteve Seedhouse's Stock Forecasts
AnalystsSteve Seedhouse
Sectors:
Analyst Ranking
Top 26%
#1370 out of 5263 analysts
Average Return
+14.45%
Win Rate
75%15 out of 20
Risk vs Reward
Poor
Good
Steve Seedhouse's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Apellis Pharmaceuticals IncAPLS | +128.90% | $17.89 | $40.95 | 2026-03-17 - 2026-04-27 | Strong Buy |
Apellis Pharmaceuticals IncAPLS | +91.98% | $21.33 | $40.95 | 2026-01-12 - 2026-04-27 | Strong Buy |
Apellis Pharmaceuticals IncAPLS | +78.43% | $22.95 | $40.95 | 2025-07-31 - 2026-04-27 | Strong Buy |
Camp4 Therapeutics CorpCAMP | +48.99% | $2.98 | $4.44 | 2025-10-01 - 2026-04-27 | Strong Buy |
Innoviva IncINVA | +24.45% | $18.77 | $23.36 | 2025-07-10 - 2026-04-27 | Strong Buy |
Steve Seedhouse Analyst Color
Get additional color on Steve Seedhouse's coverage of popular stocks
Steve Seedhouse's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Opus Genetics IncIRD | 1 | Strong Buy | $15.00 | +192.97% | Initiates Coverage On | a month ago |
Surrozen IncSRZN | 2 | Strong Buy | $40.00 | +33.56% | Reiterates | a month ago |
Apellis Pharmaceuticals IncAPLS | 3 | Strong Buy | $31.00 | -24.30% | Maintains | a month ago |
Korro Bio IncKRRO | 2 | Strong Buy | $22.00 | +71.34% | Maintains | 2 months ago |
Harrow IncHROW | 2 | Strong Buy | $91.00 | +119.75% | Maintains | 2 months ago |
Belite Bio IncBLTE | 2 | Strong Buy | $266.00 | +63.13% | Maintains | 2 months ago |
Wave Life Sciences LtdWVE | 2 | Strong Buy | $41.00 | +490.78% | Maintains | 3 months ago |
Xencor IncXNCR | 2 | Strong Buy | $42.00 | +220.61% | Maintains | 6 months ago |
Innoviva IncINVA | 2 | Strong Buy | $31.00 | +32.71% | Maintains | 6 months ago |
Camp4 Therapeutics CorpCAMP | 1 | Strong Buy | $7.00 | +57.66% | Initiates Coverage On | 7 months ago |
Tvardi Therapeutics IncTVRD | 1 | Strong Buy | $52.00 | +1,610.53% | Initiates Coverage On | 10 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.